AGENDA
7:15 - 8:30 AM: Registration, Breakfast & Exhibits
| Time | Topic | Speaker |
|---|---|---|
| 8:30 - 8:35 AM | Welcome & Opening Remarks | H. James Ford, MD Terry Fortin, MD |
| 8:35 - 9:00 AM | Pulmonary Hypertension Update 2026 | Brandon Menachem, MD |
| 9:00 - 9:35 AM | PAH Therapies: Current Controversies & Future Drug Pipeline | Robert Franz, MD |
| 9:35 - 9:45 AM | Questions & Discussion | Panelists: H. James Ford, MD Barbara LeVarge, MD |
| 9:45 - 10:20 AM | PAH with Comorbidities – Challenges & Opportunities | H. James Ford, MD or guest faculty |
| 10:20 - 10:30 AM | Questions & Discussion | Panelists: Terry Fortin, MD Abhijit Raval, MD |
10:30 - 10:45 AM: Break & Exhibits
| Time | Topic | Speakers |
|---|---|---|
| 10:45 - 11:00 AM | Technology in PAH: CardioMEMS, Actigraphy, and AI | Sudarshan Rajagopal, MD, PhD |
| 11:00 - 11:10 AM | Questions & Discussion | Panelists: Terry Fortin, MD David Ishizawar, MD |
| 11:10 - 11:35 AM | Challenging & Interesting Cases in PH 1 | Emory Buck, MD Denise Sese, MD Abhijit Raval, MD Willard Applefeld, MD |
| 11:35 - noon | Challenging & Interesting Cases in PH 2 | Jacob Pierce, MD Lisa Rose-Jones, MD Veeranna Maddipati, MD Brandon Menachem, MD |
Noon - 1:30 PM Lunch & Exhibits
| Time | Topic | Speaker |
|---|---|---|
| 12:30 - 1:00 PM (Optional non-CME session, held in Junior Ballroom D) | YUTREPIA® (treprostinil) inhalation powder: a prostacyclin treatment for your PAH & PH-ILD patients Sponsored by Liquidia Technologies, Inc. | Sponsored Speaker TBD |
| 1:30 - 2:05 PM | 2026 AHA/ACC Acute PE Guidelines: A Case-Based Approach to Acute Management & Follow Up | Geoffrey Barnes, MD |
| 2:05 - 2:25 PM | Questions & Case-Based Discussion | Panelists: Daniel Loriaux, MD Joseph Rossi, MD, MSCI Charles Kim, MD Divya Verma, MD |
2:25 - 2:40 PM Break & Exhibits
| Time | Topic | Speaker |
|---|---|---|
| 2:40 - 3:05 PM | Acute PE Management Talk | W. Cameron McGuire, MD, MPH |
| 3:05 - 3:30 PM | CTEPH Talk | Divya Verma, MD |
| 3:30 - 3:40 PM | Symposium Recap & Closing Remarks | H. James Ford, MD Terry Fortin, MD |